We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

  • Facebook
  • Twitter
  • Linked In
  • Google+
back top

1300 members from 70 countries Join ICRS

Press Release: Piramal Canada sells BST Cargel to S&N

Press Release: Piramal Enterprises announces sale of its Canada-based cartilage repair product, BST-CarGel® to Smith & Nephew Montreal, January 12, 2016: Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302) today announces the sale of BST-CarGel® from Piramal Healthcare (Canada) Limited, based in Montreal, Canada to Smith & Nephew (NYSE:SNN;LSE:SN), the global medical technology business. BST-CarGel® is a first-line cartilage repair product used along with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears. Through this transaction, an affiliate of Smith & Nephew plc will acquire ownership of all product and intellectual property assets related to BST-CarGel.

Press Release: Piramal Enterprises…
Press Release: Piramal Canada sells BST Cargel to S&N